AkritiGJain Profile Banner
Akriti Jain Profile
Akriti Jain

@AkritiGJain

Followers
612
Following
438
Media
21
Statuses
157

Leukemia and Myeloid Disorders Physician at @ClevelandClinic. Proud Alumni @MoffittNews, @adventhealth Orlando, DMC Ludhiana. Mom of 2! Tweets are my own

Cleveland, OH
Joined September 2021
Don't wanna be here? Send us removal request.
@OncLive
OncLive.com
1 month
It's time for the #FiveUnder5 🕓, your go-to roundup of the top 5 #oncology videos of the week. @bvantine1 @washumedicine @AkritiGJain @ClevelandClinic @AlexisLeVee @cityofhope @andrew02114 @MGHCancerCenter @harvardmed Watch the clips: 📽️: https://t.co/LRpuG0VuqH #bcsm #mmsm
0
2
3
@AkritiGJain
Akriti Jain
5 months
Very grateful for the opportunity and mentorship @GCC_Cortes
@GCC_Cortes
Jorge Cortes MD
8 months
A nice collaboration with Akriti Jain from @ClevelandClinic on the role of Asciminib in CML. @GACancerCenter @icmlf Asciminib: the tyrosine kinase inhibitor with a unique mechanism of action
0
1
10
@jamecancerdoc
Jame Abraham, MD, FACP
10 months
2
17
46
@AkritiGJain
Akriti Jain
10 months
0
0
2
@Matt_Cortese
Matthew Cortese, MD, MPH
10 months
1
1
6
@DavidSteensma
David Steensma, MD
10 months
Reviewing edits to consents for multicenter studies highlights how IRBs lose the plot. Their mission is to protect the rights & welfare of patients. Why is language in a consent form that was acceptable to 25 major centers not acceptable to the 26th? It just slows needed studies.
5
11
63
@AkritiGJain
Akriti Jain
10 months
May the snow gods be with us! Let's go Buffalo! #BillsMafia @JoshAllenQB @BuffaloFAMbase
1
0
5
@AkritiGJain
Akriti Jain
10 months
CML Updated from ASH 2024 - grateful for this opportunity to present at #CleClinicCancer @CleClinicMD ASH review! 1. ASC4FIRST and 2. Olverembatinib as 2L therapy 3. Impact of ASXL1 on MMR, FFS and acquisition of TKD mutations, including a poster by us!
3
5
79
@AkritiGJain
Akriti Jain
1 year
0
0
1
@TargetedOnc
Targeted Oncology
1 year
Discover what’s exciting oncologists the most at #ASH24! Key insights and breakthroughs you won’t want to miss. #ASH2024 #Oncology | @MoffittNews @AkritiGJain @ClevelandClinic @ASH_hematology https://t.co/C65FiizgOd
0
2
8
@jamecancerdoc
Jame Abraham, MD, FACP
1 year
We are looking for Director of Transplant and Cellular Therapy Program- Tremendous leadership opportunity for an outstanding physician leader to be part of one of the best hospitals in the world @ClevelandClinic @CleClinicMD !
2
11
23
@AaronGerds
Aaron Gerds MD, MS
1 year
Excited to have #OncLiveSSOS underway here in the #CLE! @OncLive @AkritiGJain @CloneTracker @CleClinicMD @caseccc
1
2
14
@drsomedeb
Somedeb Ball
1 year
It was an honor to co-lead this global effort on behalf of #MDSsm community! Learned a lot in process. Forever thankful to @Ramikomrokji for the opportunity. Hope our framework paves way for future WHO/ICC harmonization @Dr_AmerZeidan @LucaLanino @ic_MDS @VUMCHemOnc @VUMC_Cancer
@Ramikomrokji
Rami komrokji
1 year
Data-driven, harmonised classification system for MDS https://t.co/B2Ca7jZraa It took a global effort for this project using largest MDS cohort to date from Moffitt and Genomed datasets. Thx to all my dear coauthors @MoffittNews @Dr_AmerZeidan @drsomedeb @genomed4all @ic_MDS
0
7
35
@Ramikomrokji
Rami komrokji
1 year
Data-driven, harmonised classification system for MDS https://t.co/B2Ca7jZraa It took a global effort for this project using largest MDS cohort to date from Moffitt and Genomed datasets. Thx to all my dear coauthors @MoffittNews @Dr_AmerZeidan @drsomedeb @genomed4all @ic_MDS
1
19
58
@jamecancerdoc
Jame Abraham, MD, FACP
1 year
Thank you ⁦@BldCancerDoc⁩ for coming back home ⁦@ClevelandClinic⁩ for the Cancer Center for an excellent grand rounds!! ⁦@ChrisWeeMD
1
10
63